Thursday, March 19, 2026 12:45:38 AM
Yes, seeing more and more studies where CBD meshes well with other medications. IMHO, CW is in early stages (excluding Defloria) in this respect in other areas. BM stated CW is doing plarma grade research and when asked if CW is looking to partner in this respect. He responded more to come in this but it will take money.
Recent CWBHF News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:08:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:07:49 AM
- Charlotte's Web First Quarter 2026 Financial Results • Newsfile • 05/13/2026 11:07:00 AM
- OTC Markets Group Welcomes Charlotte's Web Holdings Inc. to OTCQX • GlobeNewswire Inc. • 04/30/2026 11:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/16/2026 07:03:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 07:03:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 07:02:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 04:30:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 09:07:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 06:29:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:18:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 09:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/01/2026 09:29:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:08:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:07:30 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 11:07:11 AM
- Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results • PR Newswire (US) • 03/31/2026 11:07:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 10:46:21 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/31/2026 10:45:01 AM
- Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet • PR Newswire (US) • 03/31/2026 02:59:00 AM
- Charlotte's Web 2025 Fourth Quarter and Year-End Earnings Call and Webcast Notice • PR Newswire (US) • 03/24/2026 01:15:00 PM
- Charlotte's Web Welcomes New CMS Guidance, Advancing Access to Eligible Full‑Spectrum Hemp Products • PR Newswire (US) • 03/21/2026 01:53:00 AM
